Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
- Authors
- Dusetzina, Stacie B; Farley, Joel F; Weinberger, Morris; Gaynes, Bradley N; Sleath, Betsy; Hansen, Richard A
- Year
- 2012
- Journal
- Psychiatric services (Washington, D.C.)
- PMID
- 22855210
- DOI
- 10.1176/appi.ps.201100516
- PMCID
- PMC4041154
OBJECTIVE: Recent evidence suggests that children are increasingly diagnosed as having bipolar disorder, yet no studies have quantified treatment costs for pediatric patients. The objectives of the study were to identify one-year health services utilization and treatment costs among youths newly diagnosed as having bipolar disorder. METHODS: MarketScan administrative claims from 2005 to 2007 were used to construct a retrospective person-level cohort of children ages zero to 17 to identify one-year health services utilization and costs among privately insured youths with a bipolar diagnosis. Inpatient and outpatient services were categorized as mental health related or non–mental health related. Pharmacy costs were classified as psychotropic or nonpsychotropic. RESULTS: In the sample (4,973 youths), one-year mean reimbursements for health services were $10,372, and patient out-of-pocket spending was $1,429 per child. Mental health services accounted for 71% of all health care spending, with psychotropic medications and inpatient care contributing the largest proportions of total spending (24% and 27%, respectively) . CONCLUSIONS: The costs of care among privately insured children with bipolar disorder are similar to those of adults. However, spending on children is concentrated on mental health–related services. Because private insurance plans have historically limited mental health service benefits, the concentration of spending on mental health services may place a greater burden on families for out-of-pocket payments. As mental health parity is adopted by private insurers, monitoring its impact on patient utilization and costs of health services will be important, particularly for children with serious mental illness.
Proportion of One Year Total Health Care Costs by Source of Expenditure
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy. | Tkacz J et al. | — | 2026 | → |
| Bipolar Disorder in pediatric patients: A nationwide retrospective study from 2000 to 2015. | Campos A et al. | — | 2022 | → |
| Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study. | Kadakia A et al. | — | 2021 | → |
| The Greater Houston Area Bipolar Registry-Clinical and Neurobiological Trajectories of Children and Adolescents With Bipolar Disorders and High-Risk Unaffected Offspring. | Diaz AP et al. | — | 2021 | → |
| A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial. | Goldstein TR et al. | — | 2020 | → |
| The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders. | Lee KM et al. | — | 2020 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| Out-of-pocket health expenditures in patients with bipolar disorder, anxiety, schizophrenia and other psychotic disorders: findings from a study in a psychiatry outpatient clinic in Turkey. | Islek D et al. | — | 2018 | → |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | — | 2017 | → |
| Children's Clinical Complexity Drives Psychiatric Medication Costs to Rival Hospital Costs. | Huffine C et al. | — | 2017 | → |
| Reversal-learning deficits in childhood-onset bipolar disorder across the transition from childhood to young adulthood. | Wegbreit E et al. | — | 2016 | → |
| Cost-of-illness studies for bipolar disorder: systematic review of international studies. | Jin H et al. | — | 2015 | → |
| Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. | Mertens J et al. | — | 2015 | → |
| Facial emotion recognition in childhood-onset bipolar I disorder: an evaluation of developmental differences between youths and adults. | Wegbreit E et al. | — | 2015 | → |
| Annual research review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders. | Beecham J | — | 2014 | → |
| Rapid clozapine titration in treatment-refractory bipolar disorder. | Ifteni P et al. | — | 2014 | → |